Fifth Third Bancorp Ultragenyx Pharmaceutical Inc. Transaction History

Fifth Third Bancorp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$39.87 - $69.36 $39 - $69	-1 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $4,900 - $9,739	-126 Reduced 99.21%	1 $0
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $7,970 - $10,006	-111 Reduced 46.64%	127 $10,000
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $35,398 - $46,601	-813 Reduced 77.35%	238 $11,000
Q3 2017 Nov 14, 2017	SELL	$49.79 - $66.32 $9,758 - $12,998	-196 Reduced 15.72%	1,051 $56,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,247	1,247 $77,000

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.